Elite Pharmaceuticals, Inc. (OTC: ELTP)


Date: 
Sat, 10/10/2009

TNS members were alerted to OTC traded ELTP at $.09 on pending drug trials.  ELTP closed on 10/20/09 at .25 yielding a 28% ROI.


TooNiceStocks.com was not compensated for profiling this company. Rather we have initiated our own independent research. As always read full disclaimer here.



Join our Free Newsletter!